Author: Joseph R Fauver; Mary E. Petrone; Emma B Hodcroft; Kayoko Shioda; Hanna Y Ehrlich; Alexander G. Watts; Chantal B.F. Vogels; Anderson F. Brito; Tara Alpert; Anthony Muyombwe; Jafar Razeq; Randy Downing; Nagarjuna R. Cheemarla; Anne L Wyllie; Chaney C. Kalinich; Isabel Ott; Josh Quick; Nicholas J. Loman; Karla M. Neugebauer; Alexander L. Greninger; Keith R. Jerome; Pavitra Roychoundhury; Hong Xie; Lasata Shrestha; Meei-Li Huang; Virginia E. Pitzer; Akiko Iwasaki; Saad B. Omer; Kamran Khan; Isaac Bogoch; Richard A. Martinello; Ellen F. Foxman; Marie-Louise Landry; Richard A Neher; Albert I Ko; Nathan D. Grubaugh
Title: Coast-to-coast spread of SARS-CoV-2 in the United States revealed by genomic epidemiology Document date: 2020_3_26
ID: 8m06zdho_24
Snippet: Residual de-identified nasopharyngeal samples testing positive for SARS-CoV-2 by reverse-transcriptase quantitative (RT-q)PCR were obtained from the Yale-New Haven Hospital Clinical Virology Laboratory or the Connecticut State Department of Public Health. In accordance with the guidelines of the Yale Human Investigations Committee and the Connecticut State Department of Public Health, this work with de-identified samples is considered non-human s.....
Document: Residual de-identified nasopharyngeal samples testing positive for SARS-CoV-2 by reverse-transcriptase quantitative (RT-q)PCR were obtained from the Yale-New Haven Hospital Clinical Virology Laboratory or the Connecticut State Department of Public Health. In accordance with the guidelines of the Yale Human Investigations Committee and the Connecticut State Department of Public Health, this work with de-identified samples is considered non-human subjects research. All samples were de-identified before receipt by the study investigators.
Search related documents:
Co phrase search for related documents- nasopharyngeal sample and positive test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- nasopharyngeal sample and reverse transcriptase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- nasopharyngeal sample and reverse transcriptase quantitative: 1, 2
- nasopharyngeal sample and study investigator: 1, 2
- positive test and reverse transcriptase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- positive test and reverse transcriptase quantitative: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- positive test and SARS reverse transcriptase quantitative: 1, 2
- positive test and study investigator: 1, 2, 3, 4, 5, 6
- reverse transcriptase and SARS reverse transcriptase quantitative: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- reverse transcriptase and study investigator: 1
- reverse transcriptase quantitative and SARS reverse transcriptase quantitative: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
Co phrase search for related documents, hyperlinks ordered by date